.avif)
Sarepta Therapeutics Email Format
Biotechnology Research
・
501-1,000 employees
・
Cambridge, MA, USA
Sarepta Therapeutics is a global biotechnology company focused on engineering precision genetic medicines for rare diseases, headquartered in Cambridge, Massachusetts.
Search our verified sources for decision-makers, emails, and titles.
Start searching
VERIFIED BY CLAY
firstinitiallast@sarepta.com
Company Overview
Industry
Biotechnology Research
Founded
1980
Headquarters
Cambridge, MA, USA
Revenue
$1B-$2.5B
FUNDING Stage
Public
Website
Key Executives
Douglas S. Ingram (Chief Executive Officer), Ryan H. Wong (Executive Vice President, Chief Financial Officer), Ian M. Estepan (President and Chief Operating Officer)
Tech Stack
Key Executives
4.9/5 on G2
40K+ GTM professionals
SOC 2 Type II certified
Frequently Asked Questions
What is the email format of Sarepta Therapeutics?
Sarepta Therapeutics uses the firstinitiallast format, so Jane Smith would be jsmith@sarepta.com.
What FDA-approved products does Sarepta Therapeutics currently have on the market?
Sarepta Therapeutics has four FDA-approved therapies on the market: ELEVIDYS, EXONDYS 51, VYONDYS 53, and AMONDYS 45, all targeting Duchenne muscular dystrophy. ELEVIDYS is the company's gene therapy, while the other three are RNA-based PMO therapies.
How large is Sarepta Therapeutics as a company?
Sarepta Therapeutics has approximately 1,158 employees and is headquartered in Cambridge, MA. The company generated over $330 million in net product revenues in the first quarter of 2026 alone.
Who leads Sarepta Therapeutics' day-to-day operations in 2026?
Sarepta Therapeutics is led by Douglas S. Ingram as Chief Executive Officer, with Ian M. Estepan serving as President and Chief Operating Officer and Ryan H. Wong as Executive Vice President and Chief Financial Officer.
Does Sarepta Therapeutics have any presence outside the United States?
Yes, Sarepta Therapeutics has an international footprint. As of 2026, ELEVIDYS was commercially launched in Japan by Chugai Pharmaceuticals, and Sarepta received a Japan milestone payment as part of that collaboration. Tools like Clay can help identify the right Sarepta contacts for specific regions.
Get access to more people and company data using Clay
Leverage the power of 100+ data providers for industry-leading data coverage & quality.
4.9 rating